{"RecieveEnt":"山东宏济堂制药集团股份有限公司","PayEnt":"中兵慧明/巨擎资本","Money":"RMB1.3亿","Rounds":"新三板定增轮","Url":"https://zdb.pedaily.cn/inv/show8712/","Sn":"8712","Title":"巨擎资本、中兵广发投资基金投资宏济堂6.58%股权","Date":"2017年03月29日","Industry":"生物技术/医疗健康 > 医药 > 中药材及中成药加工业"}